Camber Pharmaceuticals adds bexarotene capsules to its portfolio. Bexarotene capsules are indicated for the treatment of cutaneous manifestations of cutaneous T-cell lymphoma in patients who are refractory to at least one prior systemic therapy. The capsules (75 mg) are available in 100-count bottles. Additional information can be found online.